↧
Novartis, Valeant bids herald new deal-making era for pharma
↧
Why Valeant International Inc. Is Acquiring Botox and Juvederm Maker Allergan
↧
↧
Allergan poison pill presages a battle against Valeant's $47B takeover
↧
[video] Why Is the Drug Industry in a Deal Frenzy?
↧
Allergan sales force key to Valeant chief's plans for post-merger growth
Fierce Pharma Marketing
↧
↧
Allergan can do better than Valeant offer, investor says
↧
Allergan made a pass at Shire before Valeant came calling
Fierce Biotech
↧
Biotech M&A is MIA
TheStreet.com
↧
Allergan likely to receive higher bid from Valeant, says Sterne Agee
Yahoo/Fly on the Wall
↧
↧
Irreconcilable differences? Allergan investors wary of suitor Valeant's cost-slashing style
↧
Allergan Said to Explore Sale to Sanofi, J&J
↧
Shire Gains on Report Allergan Is Preparing Takeover Bid
↧
Up, up, up: After Allergan offer, would-be buyer Ackman reaps $1.2B in gains
↧
↧
Allergan Reports Strong Q1 While Weighing Valeant Bid
Investors.com
↧
Allergan board unanimously rejects cash-stock takeover offer from Valeant Pharma
↧
Allergan CEO says 'rumor mill' inconsistent with company history of discreteness
The Fly on the Wall
↧
Valeant May Improve Allergan Bid on Investor Feedback
↧
↧
Mergers seem to be a prescription for growth for pharmaceuticals
Yahoo/Market Realist
↧
Valeant to consider breakup after mega deals -investors
↧
Ackman says Allergan CEO has conflict of interest on takeover offer
↧